Suchergebnisse - "CHO SEOK GOO"

PubPharm (443)

1

TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Lee, J. | Im, K. | Gil, S. | +4

2

TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and $ CD8^{+} $ T cell priming

enthalten in: Cancer immunology immunotherapy | 2024

von Lee, J. | Im, K. | Gil, S. | +4

3

Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

enthalten in: ResearchSquare.com | 2024

von Kim, H. | Park, S. | Bang, S. | +18

4

Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

enthalten in: Bone marrow transplantation | 2024

von Park, S. | Bang, S. | Kwag, D. | +18

5

Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab

enthalten in: Annals of hematology | 2024

von Qing, M. | Zhou, T. | Perova, T. | +19

6

Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients

enthalten in: Cytotherapy | 2023

von Jeon, Y. | Kim, T. | Min, G. | +12

7

Long-term Clinical Outcomes of Optimizing Combination Therapy for Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma : A Retrospective Study

enthalten in: Acta haematologica | 2023

von Min, G. | Rhee, C. | Kim, T. | +5

8

The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma

enthalten in: Scientific reports | 2023

von Min, G. | Jeon, Y. | Kim, T. | +16

9

Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Choi, W. | Han, E. | O, J. | +8

10

A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea

enthalten in: Expert opinion on biological therapy | 2023

von Jo, J. | Jeon, Y. | Kim, D. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]